Tag Archives: Healthcare

ISPOR, Optum and the Power of Real-World Data

The life sciences industry is facing unprecedented opportunities and challenges, and I’m excited. We’re entering new and diverse markets, unlike any we’ve experienced before, while at the same time the dynamics in existing markets are becoming more complex due to health care transformation efforts.

Living the Promise of Big Data Part I

The promise of big data is potentially revolutionary for health care; it will ease the transition to authentic data-driven decision-making, enabling payers to more effectively understand the needs of specific groups of members and ultimately improve standards of care.  Practically speaking, however, the vastness of the data that health plans can access presents unique challenges […]
Read More »

ACO Governance: Align Functions of the Operations Team to a Common Goal

This post is the second of an 11-part series that proposes structures and actions that characterize successful accountable care organizations. As mentioned in the previous blog post , the operational leadership team of an ACO should be comprised of senior-level leaders who have the authority and accountability to make and implement changes to day-to-day operations. These […]
Read More »

Four Steps to Assess HIE Readiness

A health information exchange (HIE) framework is essential for health care organizations to achieve their goals of better coordinating patient care, meeting meaningful use stage two requirements and participating in Accountable Care Organizations (ACO). Although many health care leaders recognize the value and benefits of creating an HIE, many are unsure of where to begin […]
Read More »

Navigating the Journey from Providing Care to Managing Health

Health care’s “Triple Aim”—the goal of simultaneously improving quality, lowering costs, increasing patient satisfaction—is not a passing fad. It’s good business. Forward-looking organizations see that focusing on the Triple Aim will give them strategic advantages in contracting and in marketing, and help them gain market share. They also see that to achieve these aims, they […]
Read More »

ACO governance and organization models must build in accountability for providing integrated, high quality care—at a lower cost

This post is the first of an 11-part series that proposes structures and actions that characterize successful accountable care organizations. There are currently between 25 million and 31 million people receiving care through Accountable Care Organizations. ACOs are among efforts underway to improve the way the health system serves people, with a strong focus on […]
Read More »

CMS Quality Star Ratings Offer Opportunity for Adherence Evidence Generation

The Centers for Medicare & Medicaid Services’ (CMS) has implemented a five-star rating system for MedicareAdvantage and Part D health plans including measures of patient medication adherence for diabetes, hypertension and hypercholesterolemia. At the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting, my colleagues and I discussed how these new adherence requirements […]
Read More »

What’s the “Best” Data?–The Data That Can Answer the Question!

In a previous post by my colleague Dr. Aylin Altan Riedel, she presented an overview of Analyze This!, an educational symposium sponsored by Optum Life Sciences at the 18th Annual International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting. I’m pleased to be a part of this panel discussion focused on getting the […]
Read More »

Analyze This! ISPOR panel to discuss Big Data, The Cloud and Real World Evidence

Each year at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting, the Optum Life Sciences group hosts an educational symposium before the attending global researchers and thought leaders. At this year’s 18th ISPOR gathering, I’m pleased to moderate an important educational symposium to be held tomorrow titled, “Analyze This! Getting the […]
Read More »

ISPOR: Focusing on the Patient

For the past 17 years, attendance at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting has grown from under 500 in attendance at the first conference held in 1996 to an expected turnout of more than 3,000 during the May 18-22, 2013 meeting in New Orleans.